Table 2.

Distribution of Changes From Baseline in PSA by Visit and Treatment

Group/Visit	N	25th Percentile (ng/mL)	Median (ng/mL)	75th Percentile (ng/mL)	90th Percentile (ng/mL)	95th Percentile (ng/mL)	97.5th Percentile (ng/mL)	Max (ng/mL)
Testosterone
Month 3	369	0.0	0.2	0.4	0.8	1.2	1.5	3.4
Month 12	359	0.0	0.2	0.6	1.2	1.7	3.4	10.6
Month 18	331	−0.2	0.0	0.3	0.7	1.0	1.4	3.8
Placebo
Month 3	372	−0.1	0.0	0.2	0.5	0.6	1.1	5.4
Month 12	341	−0.1	0.0	0.2	0.6	0.8	1.1	6.7
Month 18	317	−0.1	0.0	0.2	0.6	1.1	2.7	4.1